X0202 4 2005-12-22 0 0000786947 ACURA PHARMACEUTICALS, INC ACUR.OB 0001260882 REDDICK ANDREW D C/O ACURA PHARMACEUTICALS, INC. 616 N. NORTH COURT, SUITE 120 PALANTINE IL 60067 1 1 0 0 President and CEO Common Stock 2005-12-22 4 A 0 8250000 A 8250000 D Grant is a grant of Restricted Stock Units. Restricted Stock Units represent rights to an equivalent number of shares of Common Stock of the Issuer. Upon issuance of Common Stock under the Restricted Stock Units, holders of Restricted Stock Units must pay par value ($.01) for each share acquired. Restricted Stock Units vest as follows: 2,750,000 units vest upon issuance and 229,166.67 (2.7778%) of such units vest on the first day of each month beginning January 1, 2006 and ending December 1, 2007. Absent a change of control, 2,062,500 shares of common stock will be distributed under the Restricted Stock Units (after payment of $.01 par value per share) on January 1st of each of 2011, 2012, 2013 and 2014. If a change of control occurs (whether prior to or after 2011), one share of common stock will be distributed for each outstanding Restricted Stock Unit (after payment of $0.01 per share par value) at or about the time of the change of control. /s/ Andrew D. Reddick 2005-12-22